1-12 of 12
Weiping Zhang
Close
Sort by
Journal Articles

The Promising Third-Generation TKI Olverembatinib in Adult BCR::ABL1-Positive Acute Lymphoblastic Leukemia with T315I Mutation and Relapsed/Refractory Disease

Weiyang Liu, Cheng Wang, Sijie Tang, Jiayi Ren, Lijun Peng, Yongmei Zhu, Xiangqin Weng, Wanyan Ouyang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jin Wang, Jian-Qing Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 5902.
https://doi.org/10.1182/blood-2023-188733
Published: 2023
Journal Articles

The Prognostic Significance of 1-Year Persistent MRD Negativity in Chinese ALL Patients: 5-Year Follow-up Results from RJ-ALL 2014 Trial

Jiayi Ren, Sijie Tang, Weiyang Liu, Xiangqin Weng, Cheng Wang, Lijun Peng, Wenqian Xu, Yuxuan Shang, Jie Hao, Wenyan Yu, Jiaojiao Zhang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jin Wang, Jian-Qing Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6057.
https://doi.org/10.1182/blood-2023-189710
Published: 2023
Journal Articles

Dose Escalation of Blinatumomab Is a Better Option for MRD-Positive CR Patients, Results from a Single-Center Real World Study of Blinatumomab for B-Cell Acute Lymphoblastic Leukemia in China

Sijie Tang, Jiayi Ren, Weiyang Liu, Xiangqin Weng, Yongmei Zhu, Cheng Wang, Lijun Peng, Wenqian Xu, Yuxuan Shang, Wenyan Yu, Jiaojiao Zhang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jian-Qing Mi, Jin Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5885.
https://doi.org/10.1182/blood-2023-189703
Published: 2023
Journal Articles

A Phase II Study of Flumatinib with Chemotherapy for Newly Diagnosed BCR::ABL1-Positive Acute Lymphoblastic Leukemia in Adults: Updated Results from RJ-ALL2020.2A Trial

Weiyang Liu, Cheng Wang, Sijie Tang, Jiayi Ren, Lijun Peng, Yongmei Zhu, Xiangqin Weng, Wanyan Ouyang, Jie Xu, Yuanfang Liu, Weiping Zhang, Jian-Qing Mi, Jin Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5880.
https://doi.org/10.1182/blood-2023-180326
Published: 2023
Journal Articles

A Risk Score Combined Clinical and Molecular Profiles Identifies a High-Risk Subgroup within Intermediate-Risk Acute Myeloid Leukemia

Xiaoxia Hu, Aijie Huang, Qi Chen, Ying Zhang, Lixia Liu, Chengcheng Wang, Weiping Zhang, Jianmin Yang, Jianmin Wang
Journal: Blood
Blood (2019) 134 (Supplement_1): 2713.
https://doi.org/10.1182/blood-2019-129186
Published: 2019
Journal Articles

FISH + CD34 + CD38 - Cells Detected In Newly Diagnosed Acute Myeloid Leukemia Patients Can Predict The Clinical Outcome

Libing Wang, Xiaoxia Hu, Lei Gao, Sheng Xu, Shenglan Gong, Li Chen, Shuqing Lü, Jie Chen, Huiying Qiu, Xiaoqian Xu, Xiong Ni, Xianmin Song, Weiping Zhang, Jianmin Yang, Min Liu, Jianmin Wang, MD
Journal: Blood
Blood (2013) 122 (21): 1379.
https://doi.org/10.1182/blood.V122.21.1379.1379
Published: 2013
Journal Articles

Minimal Residual Disease Monitored With Fluorescence In Situ Hybridization (FISH) In CD34 + CD38 - Population Predicts Clinical Outcome In Core Binding Factor Acute Myeloid Leukemia (CBF-AML)

Xiaoxia Hu, Libing Wang, Lei Gao, Sheng Xu, Shenglan Gong, Min Liu, Huiying Qiu, Xiaoqian Xu, Xiong Ni, Li Chen, Shuqing Lü, Jie Chen, Xianmin Song, Weiping Zhang, Jianmin Yang, Jianmin Wang, MD
Journal: Blood
Blood (2013) 122 (21): 1356.
https://doi.org/10.1182/blood.V122.21.1356.1356
Published: 2013
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) with FBA/FBAA Regimen Based Reduced-Intensity Conditioning: A Multicenter Clinical Trial in China

Jianmin Wang, Weiping Zhang, Jiong Hu, Chun Wang, Xinghua Chen, Jian Hou, MD, Yongping Song
Journal: Blood
Blood (2011) 118 (21): 1953.
https://doi.org/10.1182/blood.V118.21.1953.1953
Published: 2011
Journal Articles

Reduced-Intensity Conditioning with FBA/FBAA Regimen Is Feasible for Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML): Interim Results of a Multicenter Clinical Trial in China.

Jianmin Wang, M.D., Jiong Hu, M.D., Chun Wang, M.D., Xinghua Chen, M.D., Jian Hou, M.D., Weiping Zhang, M.D., Wei Tang, M.D., Shike Yan, M.D., Xi Zhang, M.D., Lili Zhou, M.D., Jun Hou, M.D.
Journal: Blood
Blood (2009) 114 (22): 196.
https://doi.org/10.1182/blood.V114.22.196.196
Published: 2009
Journal Articles

A Homoharringtonine-Based Protocol Is Superior to Daunorubicin and Idarubicin-Based Protocols in Elderly Patients with Newly-Diagnosed Acute Myeloid Leukemia with Comparable Effects and Low Toxicities: Experience in a Chinese Center.

Jianmin Wang, MD, Shuqing Lü, Jianmin Yang, Xianmin Song, Li Chen, Jun Hou, Weiping Zhang, Chongmei Huan, Xiong Ni, Huiying Qiu
Journal: Blood
Blood (2008) 112 (11): 1946.
https://doi.org/10.1182/blood.V112.11.1946.1946
Published: 2008
Journal Articles

Reduced-Intensity Conditioning Versus Conventional Regimen for Allogeneic Peripheral Blood Hematopoietic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia.

Jianmin Wang, MD, Weiping Zhang, MD, Caobo Feng, MD, Xianmin Song, MD, Xiong Ni, MD, Xiaoxia Hu, BS, Lei Gao, MS, Hong Zhou, BS, Hongmei Li, BS, Xiaoqin Ding, BS
Journal: Blood
Blood (2005) 106 (11): 5299.
https://doi.org/10.1182/blood.V106.11.5299.5299
Published: 2005
Journal Articles

Novel heat shock protein Hsp70L1 activates dendritic cells and acts as a Th1 polarizing adjuvant

Tao Wan, Xiangyang Zhou, Guoyou Chen, Huazhang An, Taoyong Chen, Weiping Zhang, Shuxun Liu, Yingming Jiang, Feng Yang, Yanfeng Wu, Xuetao Cao
Journal: Blood
Blood (2004) 103 (5): 1747–1754.
https://doi.org/10.1182/blood-2003-08-2828
Published: 2004